FSH continues to be an interesting test on ovarian reserve investigation, since it is an easily accessible and low-cost marker, and that could be useful in pretreatment evaluation of specific groups of infertile women, such as those carrying anovulatory cycles [31], endometriosis [32] or in patients over 35 years of age [33]. The gene discussed is BRD2; the disease is Infertility.